drugset / Trial / NCT00802035

ALK29-002: A Study of Baclofen Formulations in Healthy Adults

NCT00802035

Phase 1 Completed 16 enrolled Alkermes, Inc.
Non-randomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to determine the pharmacokinetics, safety, and tolerability of different baclofen formulations.

Timeline

Start
2008-11
Primary completion
2008-12
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Baclofen Small molecule 30 mg

Indications